FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2404261729> ?p ?o ?g. }

• W2404261729 endingPage "1354" @default.
• W2404261729 startingPage "1349" @default.
• W2404261729 abstract "Abstract The capacity to generate lymphokine-activated killer (LAK) cells and the susceptibility of the neoplastic cells to both allogeneic and autologous LAK effectors were studied in B and T chronic lymphoproliferative disorders. While in B-cell chronic lymphocytic leukemia (B-CLL) the depressed natural killer function could be restored after a 7-day incubation with recombinant interleukin (IL-2), B-CLL mononuclear cells showed a reduced LAK activity compared with normal LAK cells. Furthermore, in all but 1 of the 20 B-CLL samples tested the leukemic cells were totally resistant to autologous LAK effectors. In most cases the leukemic cells were also resistant to normal allogeneic LAK cells. Competition experiments demonstrated that the patients' LAK cells, as well as normal LAK effectors, were capable of recognizing B-CLL cells, pointing, therefore, to a postbinding cytolytic defect. In hairy cell leukemia (HCL) an overall reduced LAK activity against allogeneic targets was documented, but, at variance from B-CLL, hairy cells were often susceptible to the lytic effect of normal LAK cells, and in half of the cases tested the neoplastic population was also sensitive in an autologous system. Similarly to B- CLL, in the great majority of T chronic lymphoproliferative disorders studied, the pathologic cells were resistant to normal and autologous LAK effectors and a defective LAK generation was found. These results demonstrate that in most B and T chronic leukemias the LAK function is defective and, when inducible, does not appear directed against the leukemic population. The possibility of exploiting an immunotherapeutic approach with IL-2/LAK cells in the management of chronic lymphoproliferative disorders does not gain support by these findings." @default.
• W2404261729 created "2016-06-24" @default.
• W2404261729 creator A5015546827 @default.
• W2404261729 creator A5016050318 @default.
• W2404261729 creator A5017300347 @default.
• W2404261729 creator A5018515443 @default.
• W2404261729 creator A5032968890 @default.
• W2404261729 creator A5033476268 @default.
• W2404261729 creator A5047961182 @default.
• W2404261729 creator A5050588157 @default.
• W2404261729 creator A5072698345 @default.
• W2404261729 creator A5082189528 @default.
• W2404261729 date "1990-10-01" @default.
• W2404261729 modified "2023-10-15" @default.
• W2404261729 title "Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors" @default.
• W2404261729 cites W108417128 @default.
• W2404261729 cites W1572020652 @default.
• W2404261729 cites W1865869715 @default.
• W2404261729 cites W1985981664 @default.
• W2404261729 cites W1994330825 @default.
• W2404261729 cites W2001790233 @default.
• W2404261729 cites W2009807365 @default.
• W2404261729 cites W2018438577 @default.
• W2404261729 cites W2036275492 @default.
• W2404261729 cites W2084361130 @default.
• W2404261729 cites W2090864394 @default.
• W2404261729 cites W2116842299 @default.
• W2404261729 cites W2120979416 @default.
• W2404261729 cites W2141278010 @default.
• W2404261729 cites W2145498103 @default.
• W2404261729 cites W2146250143 @default.
• W2404261729 cites W2147269655 @default.
• W2404261729 cites W2153807062 @default.
• W2404261729 cites W2204724075 @default.
• W2404261729 cites W2322553446 @default.
• W2404261729 cites W2326245275 @default.
• W2404261729 cites W2361587666 @default.
• W2404261729 cites W237185628 @default.
• W2404261729 cites W2400507627 @default.
• W2404261729 cites W2401866239 @default.
• W2404261729 cites W2403027605 @default.
• W2404261729 cites W2403398749 @default.
• W2404261729 cites W2415381909 @default.
• W2404261729 cites W2416847343 @default.
• W2404261729 cites W2430174839 @default.
• W2404261729 doi "https://doi.org/10.1182/blood.v76.7.1349.1349" @default.
• W2404261729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2207312" @default.
• W2404261729 hasPublicationYear "1990" @default.
• W2404261729 type Work @default.
• W2404261729 sameAs 2404261729 @default.
• W2404261729 citedByCount "36" @default.
• W2404261729 countsByYear W24042617292016 @default.
• W2404261729 countsByYear W24042617292022 @default.
• W2404261729 countsByYear W24042617292023 @default.
• W2404261729 crossrefType "journal-article" @default.
• W2404261729 hasAuthorship W2404261729A5015546827 @default.
• W2404261729 hasAuthorship W2404261729A5016050318 @default.
• W2404261729 hasAuthorship W2404261729A5017300347 @default.
• W2404261729 hasAuthorship W2404261729A5018515443 @default.
• W2404261729 hasAuthorship W2404261729A5032968890 @default.
• W2404261729 hasAuthorship W2404261729A5033476268 @default.
• W2404261729 hasAuthorship W2404261729A5047961182 @default.
• W2404261729 hasAuthorship W2404261729A5050588157 @default.
• W2404261729 hasAuthorship W2404261729A5072698345 @default.
• W2404261729 hasAuthorship W2404261729A5082189528 @default.
• W2404261729 hasBestOaLocation W24042617291 @default.
• W2404261729 hasConcept C129374314 @default.
• W2404261729 hasConcept C147483822 @default.
• W2404261729 hasConcept C203014093 @default.
• W2404261729 hasConcept C2776090121 @default.
• W2404261729 hasConcept C2777371288 @default.
• W2404261729 hasConcept C2777938653 @default.
• W2404261729 hasConcept C2778461978 @default.
• W2404261729 hasConcept C2778690821 @default.
• W2404261729 hasConcept C28651165 @default.
• W2404261729 hasConcept C2908647359 @default.
• W2404261729 hasConcept C49382859 @default.
• W2404261729 hasConcept C502942594 @default.
• W2404261729 hasConcept C71924100 @default.
• W2404261729 hasConcept C86803240 @default.
• W2404261729 hasConcept C8891405 @default.
• W2404261729 hasConcept C99454951 @default.
• W2404261729 hasConceptScore W2404261729C129374314 @default.
• W2404261729 hasConceptScore W2404261729C147483822 @default.
• W2404261729 hasConceptScore W2404261729C203014093 @default.
• W2404261729 hasConceptScore W2404261729C2776090121 @default.
• W2404261729 hasConceptScore W2404261729C2777371288 @default.
• W2404261729 hasConceptScore W2404261729C2777938653 @default.
• W2404261729 hasConceptScore W2404261729C2778461978 @default.
• W2404261729 hasConceptScore W2404261729C2778690821 @default.
• W2404261729 hasConceptScore W2404261729C28651165 @default.
• W2404261729 hasConceptScore W2404261729C2908647359 @default.
• W2404261729 hasConceptScore W2404261729C49382859 @default.
• W2404261729 hasConceptScore W2404261729C502942594 @default.
• W2404261729 hasConceptScore W2404261729C71924100 @default.
• W2404261729 hasConceptScore W2404261729C86803240 @default.
• W2404261729 hasConceptScore W2404261729C8891405 @default.
• W2404261729 hasConceptScore W2404261729C99454951 @default.

• next